Complete Genomics (GNOM) Continues Run Following Strong LFR Testing Data
Tweet
Share
E-mailGet Alerts GNOM Hot Sheet
Join SI Premium – FREE
Complete Genomics (Nasdaq: GNOM) is up again in early trading, following a 44 percent run Wednesday on positive LFR Testing data.
Volatility is up slightly in early trade as shares are over 8 percent better.
Volatility is up slightly in early trade as shares are over 8 percent better.
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
